Quest Diagnostics (NYSE: DGX) reported second-quarter financial results before the regular market hours on Thursday. The Q2 earnings were a cent higher than the average Wall Street prediction, while the revenues were in line.
DGX shares fell 1.8% immediately following the announcement. The stock has gained 23% since the beginning of the year.
CEO Steve Rusckowski said, “Looking forward to the rest of the year, we will continue to expand COVID-19 testing capacity while also continuing to serve our customers as they continue to recover from the pandemic.”
Prior performance
[irp posts=”66899″]
Most Popular
LW Earnings: Key quarterly highlights from Lamb Weston’s Q3 2025 financial results
Lamb Weston Holdings, Inc. (NYSE: LW) reported its third quarter 2025 earnings results today. Net sales increased 4% to $1.52 billion compared to the same period a year ago. Net
CAG Earnings: Highlights of Conagra Brands’ Q3 2025 report
Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported a decrease in net sales and adjusted earnings for the third quarter of 2025. Net sales were
Fastenal Company (FAST) looks poised for a mixed start to FY25
Fastenal Company (NASDAQ: FAST) will report its first-quarter results on April 11, at 6:50 am ET. The company has been investing heavily to expand its digital footprint lately, and it
